Hi Otherperspective,
You mentioned in your post; ''I just wanted to reassure readers that I do not just pluck numbers out of thin air''.
However, I'm yet to be assured of this as you never responded to my question/ previous post concerning royaly rates that msb is due to receive from Takeda. I cut/pasted it below for your convenience to respond to if so inclined. Cheers
--------------------------------------------------------------
Hi Otherperspective,
Where did you come by the below rate of circa 6% ?
"Just remember that Mesoblast gets circa 6% royalty on Alofisel which EvaluatePharma has stated that global consensus sales will reach $524m by 2024 ! "
-------------------------------------------------
MSB Trading - 2019, page-1149
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.165(12.2%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.52 | $1.37 | $16.03M | 11.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4234 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 29994 | 7 |
View Market Depth
| Last trade - 12.46pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |